<!DOCTYPE html><html lang="en"><head><meta charset="UTF-8"><meta name="viewport" content="width=device-width,initial-scale=1.0"><title>Prediabetes — SugarWise</title><link rel="stylesheet" href="styles.css"></head><body>
<nav class="navbar"><div class="navbar-inner"><a class="brand" href="index.html">SugarWise</a><a class="home-link" href="index.html">All Topics</a></div></nav>
<div class="container">
<div class="page-header"><h1>Prediabetes</h1><p>The reversible stage before Type 2 diabetes — detection, lifestyle intervention, and prevention</p></div>

<div class="illus">
<svg width="280" height="110" viewBox="0 0 280 110" xmlns="http://www.w3.org/2000/svg">
<!-- Circular reversibility arrow -->
<path d="M140,20 A40,40 0 1,1 100,60" fill="none" stroke="#1a7a5a" stroke-width="3" stroke-linecap="round">
  <animate attributeName="stroke-dasharray" values="0,300;200,300" dur="2s" fill="freeze"/>
</path>
<polygon points="95,52 100,64 108,55" fill="#1a7a5a">
  <animate attributeName="opacity" values="0;1" dur="2s" fill="freeze"/>
</polygon>
<!-- Labels on the cycle -->
<text x="190" y="30" font-size="10" fill="#e53e3e" font-weight="700">Prediabetes</text>
<text x="190" y="80" font-size="10" fill="#e8913a" font-weight="600">T2D Risk</text>
<text x="60" y="30" font-size="10" fill="#38a169" font-weight="700">Normal</text>
<!-- Reversible label -->
<text x="140" y="105" text-anchor="middle" font-size="10" fill="#1a7a5a" font-weight="700">Reversible with lifestyle changes</text>
<!-- Small icons -->
<circle cx="140" cy="60" r="15" fill="#e6f5ef" stroke="#1a7a5a" stroke-width="1.5">
  <animate attributeName="r" values="15;17;15" dur="2s" repeatCount="indefinite"/>
</circle>
<text x="140" y="64" text-anchor="middle" font-size="12">&#x21BB;</text>
</svg>
</div>

<div class="section">
<h2><span class="icon-sm">&#x1F50D;</span> What Is Prediabetes?</h2>
<p>Prediabetes is a metabolic condition in which blood glucose levels are higher than normal but not yet high enough to meet the diagnostic criteria for Type 2 diabetes. It represents an intermediate state — a critical window of opportunity during which progression to diabetes can be prevented or significantly delayed through lifestyle intervention.</p>
<p>Prediabetes encompasses two related conditions:</p>
<ul>
<li><strong>Impaired Fasting Glucose (IFG):</strong> Fasting plasma glucose of 100–125 mg/dL (5.6–6.9 mmol/L).</li>
<li><strong>Impaired Glucose Tolerance (IGT):</strong> 2-hour plasma glucose of 140–199 mg/dL (7.8–11.0 mmol/L) during a 75-gram oral glucose tolerance test (OGTT).</li>
</ul>
<p>An HbA1c of <strong>5.7–6.4%</strong> is also classified as prediabetes by the ADA.</p>

<div class="warning">
<strong>Alarming Prevalence:</strong> An estimated <strong>720 million adults</strong> worldwide have impaired glucose tolerance. In the United States alone, approximately 96 million adults (38% of the adult population) have prediabetes, and over 80% of them do not know they have it.
</div>
</div>

<div class="section">
<h2><span class="icon-sm">&#x1F9EA;</span> Diagnostic Criteria</h2>
<div class="table-wrap">
<table>
<thead>
<tr><th>Test</th><th>Normal</th><th>Prediabetes</th><th>Diabetes</th></tr>
</thead>
<tbody>
<tr><td>Fasting Plasma Glucose</td><td>&lt; 100 mg/dL</td><td><strong>100–125 mg/dL</strong></td><td>&ge; 126 mg/dL</td></tr>
<tr><td>OGTT (2-hour value)</td><td>&lt; 140 mg/dL</td><td><strong>140–199 mg/dL</strong></td><td>&ge; 200 mg/dL</td></tr>
<tr><td>HbA1c</td><td>&lt; 5.7%</td><td><strong>5.7–6.4%</strong></td><td>&ge; 6.5%</td></tr>
</tbody>
</table>
</div>

<div class="note">
<strong>Note:</strong> IFG and IGT are not identical conditions. IFG primarily reflects hepatic insulin resistance, while IGT reflects peripheral (muscle) insulin resistance. Having both simultaneously carries a higher risk of progression to diabetes than having either alone.
</div>
</div>

<div class="section">
<h2><span class="icon-sm">&#x1F4C8;</span> Risk of Progression to Type 2 Diabetes</h2>
<p>Without intervention, prediabetes frequently progresses to Type 2 diabetes:</p>
<ul>
<li>Approximately <strong>5–10% of people</strong> with prediabetes progress to T2D each year.</li>
<li>Up to <strong>70% of individuals</strong> with prediabetes will eventually develop T2D in their lifetime.</li>
<li>The risk is higher in those with both IFG and IGT, higher HbA1c within the prediabetic range, obesity, family history, and certain ethnicities.</li>
<li>Even in the prediabetic stage, microvascular and macrovascular damage has begun — retinopathy has been detected in up to 8% of people with prediabetes.</li>
</ul>
</div>

<div class="section">
<h2><span class="icon-sm">&#x1F3C6;</span> The Diabetes Prevention Program (DPP)</h2>
<p>The <strong>Diabetes Prevention Program (DPP)</strong> is a landmark randomized controlled trial that demonstrated the power of lifestyle intervention in preventing T2D. Published in 2002, its results remain among the most important findings in preventive medicine.</p>

<h3>Study Design</h3>
<ul>
<li>3,234 participants with prediabetes (IGT), average age 51, average BMI 34.</li>
<li>Three groups: intensive lifestyle intervention, metformin (850 mg twice daily), and placebo.</li>
<li>Average follow-up: 2.8 years.</li>
</ul>

<h3>Key Results</h3>
<div class="table-wrap">
<table>
<thead>
<tr><th>Intervention</th><th>Reduction in T2D Risk</th><th>Details</th></tr>
</thead>
<tbody>
<tr><td><strong>Intensive Lifestyle</strong></td><td><strong>58% reduction</strong></td><td>Goal: 7% weight loss + 150 min/week physical activity</td></tr>
<tr><td><strong>Metformin</strong></td><td><strong>31% reduction</strong></td><td>850 mg twice daily</td></tr>
<tr><td>Placebo</td><td>Reference group</td><td>Standard advice only</td></tr>
</tbody>
</table>
</div>

<h3>Long-Term Follow-Up (DPPOS)</h3>
<p>The DPP Outcomes Study (DPPOS) followed participants for 15 years and found:</p>
<ul>
<li>Lifestyle intervention delayed diabetes onset by approximately <strong>4 years</strong> compared to placebo.</li>
<li>Metformin delayed onset by approximately <strong>2 years</strong>.</li>
<li>In participants aged 60 and older, lifestyle intervention reduced risk by <strong>71%</strong>.</li>
<li>Benefits persisted even after the intensive intervention phase ended.</li>
</ul>

<h3>DPP Results — Risk Reduction</h3>
<div class="progress-bar-wrap"><div class="progress-label"><span>Lifestyle Intervention</span><span>58% reduction</span></div><div class="progress-bar"><div class="progress-fill" style="width:58%"></div></div></div>
<div class="progress-bar-wrap"><div class="progress-label"><span>Metformin</span><span>31% reduction</span></div><div class="progress-bar"><div class="progress-fill orange" style="width:31%"></div></div></div>
<div class="progress-bar-wrap"><div class="progress-label"><span>Lifestyle in Age 60+</span><span>71% reduction</span></div><div class="progress-bar"><div class="progress-fill blue" style="width:71%"></div></div></div>

<div class="tip">
<strong>Key Takeaway:</strong> Lifestyle intervention was nearly twice as effective as metformin in preventing diabetes, and even more effective in older adults. This evidence forms the basis for all current prediabetes treatment guidelines.
</div>
</div>

<div class="section">
<h2><span class="icon-sm">&#x1F3C3;</span> Lifestyle Interventions — The Evidence-Based Approach</h2>

<h3>Weight Loss</h3>
<p>Weight loss is the single most impactful intervention for reversing prediabetes:</p>
<ul>
<li>A <strong>5–7% weight loss</strong> (e.g., 10–14 lbs for a 200 lb person) is the minimum target shown to significantly reduce risk.</li>
<li>Greater weight loss (&ge; 10%) provides even more benefit.</li>
<li>Even modest weight loss of 2–3 kg has measurable improvements in insulin sensitivity.</li>
<li>Weight loss should be gradual — 0.5–1 kg (1–2 lbs) per week is sustainable and safe.</li>
<li>Calorie reduction of 500–750 kcal/day below estimated needs typically achieves this rate.</li>
</ul>

<h3>Physical Activity</h3>
<ul>
<li>Target: at least <strong>150 minutes per week</strong> of moderate-intensity aerobic activity (brisk walking, cycling, swimming).</li>
<li>This translates to approximately 30 minutes, 5 days per week.</li>
<li>Resistance training 2–3 times per week provides additional insulin-sensitizing benefits by increasing muscle glucose uptake.</li>
<li>Reduce prolonged sitting — stand or walk for 3–5 minutes every 30 minutes.</li>
<li>Any increase in physical activity from a sedentary baseline is beneficial; perfection is not required.</li>
</ul>

<h3>Dietary Changes</h3>
<ul>
<li>Increase dietary fiber (target &ge; 25–30 g/day) from vegetables, whole grains, legumes, and fruits.</li>
<li>Reduce refined carbohydrates and added sugars — sugar-sweetened beverages are a major driver of insulin resistance.</li>
<li>Choose whole grains over refined grains (brown rice over white rice, whole wheat over white bread).</li>
<li>Increase intake of non-starchy vegetables, lean proteins, nuts, seeds, and healthy fats (olive oil, avocado, fatty fish).</li>
<li>Limit processed meats (bacon, sausage, deli meats) — associated with increased T2D risk independent of BMI.</li>
<li>The Mediterranean dietary pattern has demonstrated particular benefit in reducing diabetes incidence.</li>
<li>Moderate coffee consumption (3–4 cups/day) is associated with reduced T2D risk in observational studies.</li>
</ul>

<h3>Sleep and Stress</h3>
<ul>
<li>Aim for 7–8 hours of quality sleep per night. Sleep deprivation impairs glucose metabolism within days.</li>
<li>Screen for and treat obstructive sleep apnea, which is strongly linked to insulin resistance.</li>
<li>Manage chronic stress through mindfulness, meditation, physical activity, or counseling.</li>
</ul>
</div>

<div class="section">
<h2><span class="icon-sm">&#x1F48A;</span> Pharmacological Options</h2>
<p>While lifestyle intervention is first-line, medication may be considered for individuals at very high risk of progression:</p>
<ul>
<li><strong>Metformin:</strong> The ADA recommends considering metformin for prediabetes prevention, especially in those aged &lt; 60, with BMI &ge; 35, people with prior GDM, or those with rising HbA1c despite lifestyle changes. Typical dose: 500–1700 mg/day.</li>
<li><strong>Other agents studied:</strong> Acarbose (STOP-NIDDM trial — 25% risk reduction), pioglitazone (ACT NOW trial — 72% risk reduction but with weight gain and edema), and orlistat have shown benefit but are not standard recommendations due to side effects or cost-benefit considerations.</li>
<li><strong>GLP-1 receptor agonists:</strong> Semaglutide and liraglutide cause significant weight loss and improve glucose metabolism. While not formally indicated for prediabetes, they are increasingly used in obese prediabetic patients.</li>
</ul>

<div class="note">
<strong>ADA Recommendation:</strong> Lifestyle intervention remains the preferred first approach. Metformin may be added when lifestyle measures are insufficient, especially in high-risk subgroups. Annual monitoring of glucose status is recommended for all individuals with prediabetes.
</div>
</div>

<div class="section">
<h2><span class="icon-sm">&#x1F50E;</span> Screening Recommendations</h2>
<p>The ADA recommends screening for prediabetes and T2D in:</p>
<ul>
<li>All adults aged <strong>35 and older</strong>, regardless of weight or risk factors.</li>
<li>Adults of any age who are overweight (BMI &ge; 25, or &ge; 23 in Asian Americans) and have one or more additional risk factors.</li>
<li>People who had gestational diabetes — test 4–12 weeks postpartum and then every 1–3 years.</li>
<li>Children and adolescents who are overweight and have additional risk factors.</li>
</ul>
<p>If results are normal, repeat testing every 3 years. If prediabetes is detected, test annually.</p>
</div>

<div class="section">
<h2><span class="icon-sm">&#x2764;&#xFE0F;</span> Cardiovascular Risk in Prediabetes</h2>
<p>Prediabetes is not a benign condition. Even before diabetes develops, cardiovascular risk is elevated:</p>
<ul>
<li>Prediabetes is associated with a <strong>15–20% increased risk</strong> of cardiovascular events.</li>
<li>The metabolic syndrome — which often accompanies prediabetes — includes hypertension, dyslipidemia, and central obesity, all amplifying cardiovascular risk.</li>
<li>Blood pressure and lipid levels should be assessed and managed in all individuals with prediabetes.</li>
</ul>
</div>

<div class="section">
<h2><span class="icon-sm">&#x2705;</span> Can Prediabetes Be Reversed?</h2>
<p>Yes. Prediabetes is <strong>reversible</strong>. With sustained lifestyle changes — particularly weight loss and regular physical activity — many individuals can return their blood glucose levels to the normal range and significantly reduce their risk of developing Type 2 diabetes.</p>
<ul>
<li>The DPP demonstrated that lifestyle intervention can return glucose levels to normal in a significant proportion of participants.</li>
<li>Reversal is more likely when intervention begins early, before significant beta-cell loss has occurred.</li>
<li>Even individuals who do not fully normalize their glucose levels benefit from reduced risk of complications and slower progression.</li>
</ul>

<div class="tip">
<strong>Action Plan:</strong> If you have been told you have prediabetes, consider it a wake-up call — not a death sentence. Lose 5–7% of your body weight, exercise 150 minutes per week, eat more fiber and less sugar, sleep well, and follow up with your doctor regularly. These steps can change the trajectory of your health.
</div>
</div>

<div class="page-nav">
<a class="prev" href="type2-diabetes.html">Type 2 Diabetes</a>
<a class="next" href="lab-tests.html">Lab Tests</a>
</div>
</div>
<div class="footer">SugarWise is for informational purposes only. Always consult a qualified endocrinologist / diabetologist.</div>
<button class="scroll-top" id="scrollTop" title="Back to top">&uarr;</button>
<script>
var sb=document.getElementById('scrollTop');window.addEventListener('scroll',function(){sb.classList.toggle('visible',window.scrollY>400)});sb.addEventListener('click',function(){window.scrollTo({top:0,behavior:'smooth'})});
document.querySelectorAll('.accordion-header').forEach(function(h){h.addEventListener('click',function(){this.parentElement.classList.toggle('open')})});
</script>
</body></html>